Despite their contributions to the R&D of new Ebola treatments, patients, treatment providers and endemic countries do not have reliable access

This report by Resolve to Save Lives and MSF discusses access to hypertension medicines in low- and middle-income countries, and makes recommendations to reduce hypertension prevalence globally

This Strategic Framework sets out the case for a re-invigorated global drive to end cryptococcal meningitis deaths by 2030, as part of a broader drive to end all HIV-related deaths, and outlines what essential programmatic elements are ...

This Issue Brief analyses new developments in the access challenges to current and future ARVs and other critical medicines for the treatment of HIV and opportunistic infections that are responsible for the majority of HIV-related ...

AIDS related mortality remains high - 770,000 deaths in 2018 - and has hardly declined in recent years. This report, compiled by MSF, presents data from the AHD dashboard initiated by the HIV Advanced Disease Consortium (HIV-ADC).

After a decade of strong commitments to fight the twin epidemics of HIV and tuberculosis (TB), a decline in international funding and the rapid shifting of the financial burden to affected countries is in danger of reversing lifesaving ...

The Tajik Ministry of Health and Médecins Sans Frontières (MSF) began a comprehensive paediatric tuberculosis (TB) care programme in 2011. The paediatric TB project in Dushanbe aims to decrease the TB morbidity and mortality rates ...

Vaccines against pneumococcal disease and human papillomavirus are two important new tools for saving lives and protecting health. They’re also under patent - and expensive. Our report, “A Fair Shot for Vaccine Affordability,” finds ...

This report is a guide for policymakers, treatment providers and advocates interested in learning more about diagnostic and monitoring tests for HIV and hepatitis C virus (HCV), including both laboratory-based and point-of-care ...

Out of Step 2017 includes the results of a 29-country survey on national TB policies and practices. The report was created to identify gaps in implementation and monitor progress towards ending TB.

This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and ...

From 2013-2016 the UNITAID-funded MSF HIV viral load initiative has supported the scale-up of viral load testing in seven countries performing almost 320,000 viral load tests. The three years of implementation have seen both laboratory ...

Our Lives on the Edge report looks at how pharmaceutical corporation practices keep crucial medical tools out of the hands of our teams. New and affordable drugs, vaccines and diagnostics are needed urgently. Find out why these life ...

This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key ...